Skip to main content

Together we are beating cancer

Donate now

Vaccination

Showing 12 out of 44 results
Vaccine vial bottles

Researchers have been granted £1.7 million of funding from Cancer Research UK and the CRIS Cancer Foundation to develop a lung cancer vaccine Researchers have been granted £1.7 million of funding from Cancer Research UK and the CRIS Cancer Foundation to develop a lung cancer vaccine

by Sophie Wedekind | News | 22 March 2024

22 March 2024

Stained cervical cells viewed under the microscope

22-28 January is Cervical Cancer Prevention Week. To recognise that, we’ve compiled some of our most useful content on cervical cancer, from research in the lab to screening in the clinic, to get you up to date on how we can prevent cervical cancer. 22-28 January is Cervical Cancer Prevention Week. To recognise that, we’ve compiled some of our most useful content on cervical cancer, from research in the lab to screening in the clinic, to get you up to date on how we can prevent cervical cancer.

by Jacob Smith | Analysis | 22 January 2024

22 January 2024

Vaccine vial and needle

Children in England will need only one dose of the HPV vaccine to prevent cervical and other related cancers from September 2023. Children in England will need only one dose of the HPV vaccine to prevent cervical and other related cancers from September 2023.

by In collaboration with PA Media Group | News | 21 June 2023

21 June 2023

Vaccine vial and needle
  • Health & Medicine
  • Science & Technology

Cancer vaccines – where are we?

Cancer vaccine development has had many challenges. But with recent breakthroughs and new partnerships, could we be closer than ever? Cancer vaccine development has had many challenges. But with recent breakthroughs and new partnerships, could we be closer than ever?

by Sophie Wedekind | In depth | 24 February 2023

24 February 2023

CRUK and UICC’s Tobacco Control Partnership in Kenya and Uganda is launched at the World Cancer Congress

Across the diverse audience of cancer researchers, health policy professionals, government officials and cancer survivors there was a common desire at the World Cancer Congress: to make up for lost time.  Across the diverse audience of cancer researchers, health policy professionals, government officials and cancer survivors there was a common desire at the World Cancer Congress: to make up for lost time. 

by George Hayes | Analysis | 30 November 2022

30 November 2022

This entry is part 3 of 3 in the series CRUK Global
A bottle containing the HPV vaccine

From strengthening the understanding of the link between HPV and cervical cancer, to working towards reducing cervical cancer to the point where almost no one develops it, our history with this particular disease goes way back. From strengthening the understanding of the link between HPV and cervical cancer, to working towards reducing cervical cancer to the point where almost no one develops it, our history with this particular disease goes way back.

by Lilly Matson | In depth | 21 November 2022

21 November 2022

This entry is part 1 of 3 in the series CRUK Global
That Cancer Conversation in a white speech bubble with a dark blue background

Dr Ishu Kataria and her team are working out how to get the HPV vaccine to more than 70 million girls and help India 'eliminate' cervical cancer. Dr Ishu Kataria and her team are working out how to get the HPV vaccine to more than 70 million girls and help India 'eliminate' cervical cancer.

by Cancer Research UK | Podcast | 9 December 2021

9 December 2021

This entry is part 4 of 15 in the series That Cancer Conversation
A photograph of a lady holding a vaccine and needle.

We spoke to Dr Ishu Kataria who works with WHO to prevent the spread of infections like HPV, which causes 99% of cervical cancers worldwide. We spoke to Dr Ishu Kataria who works with WHO to prevent the spread of infections like HPV, which causes 99% of cervical cancers worldwide.

by Lilly Matson | In depth | 17 November 2021

17 November 2021

Two people's feet in bed.

We want to have a conversation about human papillomavirus (HPV), starting with 6 questions about HPV people frequently ask our Cancer Research UK nurses. We want to have a conversation about human papillomavirus (HPV), starting with 6 questions about HPV people frequently ask our Cancer Research UK nurses.

by Karis Betts | Analysis | 16 June 2021

16 June 2021

HPV vaccine

Long awaited study results have confirmed that the quadrivalent human papillomavirus (HPV) vaccine substantially reduces invasive cervical cancer risk.   Long awaited study results have confirmed that the quadrivalent human papillomavirus (HPV) vaccine substantially reduces invasive cervical cancer risk.  

by Cancer Research UK | News | 1 October 2020

1 October 2020